1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Current standard evaluation of Peripheral Neuropathy (PN) is based on an investigator-reported classification system that is commonly unable to correctly reflect the subjective symptoms for patients. Thus more reliable methods to assess PN are needed. This study assessed alternative methods of assessing patient-reported PN in 5 North Central Cancer Treatment Group (NCCTG) clinical trials.

          Related collections

          Author and article information

          Journal
          SOJ Anesthesiol Pain Manag
          SOJ anesthesiology & pain management
          Symbiosis Group
          2374-684X
          2374-684X
          November 4 2015
          : 2
          : 2
          Affiliations
          [1 ] Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN 55905, USA.
          [2 ] Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
          [3 ] Toledo Community Hospital Oncology Program, Toledo, OH, USA.
          Article
          NIHMS685340
          10.15226/2374-684X/2/2/00120
          4624414
          26526218
          912ac7cb-2b2c-4910-a904-2985fe4d425e
          History

          Minimum Importance Difference,Oncology Trials,Peripheral Neuropathy,Pooled Analysis,Quality of Life

          Comments

          Comment on this article